Trazodone and Pregnancy
Links shared publicly online about this topic
Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.
news-medical.net — “Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation o” View full resource at news-medical.net
Most Recently Shared on August 11, 2010 at 10:45 am By:
Pregnancy News: Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.: Labopharm Inc. to... http://bit.ly/9JufSO
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Pregnancy news and research via News-Medical.Net
Advertisement
